Relative decrease in hemoglobin and outcomes in patients undergoing kidney transplantation surgery: A retrospective cohort study.


Journal

American journal of surgery
ISSN: 1879-1883
Titre abrégé: Am J Surg
Pays: United States
ID NLM: 0370473

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 26 10 2020
revised: 09 02 2021
accepted: 01 03 2021
pubmed: 13 3 2021
medline: 7 10 2021
entrez: 12 3 2021
Statut: ppublish

Résumé

Recent surgical literature suggests that a relative decrease in hemoglobin (ΔHb) is predictive of adverse outcomes regardless of the absolute level. We aimed to examine the association between perioperative ΔHb and kidney transplantation (KT) outcomes. This was a retrospective cohort study of transplant recipients, where ΔHb = [Hb0- Hb1Hb0]x 100 (Hb Of the 899 eligible patients, 38% experienced IGF, and ΔHb was associated with 36% lower odds of IGF. Also, ΔHb was associated with higher all-cause graft failure and longer length of stay but not death-censored graft failure or mortality. ΔHb ≥30% was the threshold beyond which the odds of IGF were significantly lower even if Hb ΔHb is associated with inferior outcomes independent of Hb

Sections du résumé

BACKGROUND BACKGROUND
Recent surgical literature suggests that a relative decrease in hemoglobin (ΔHb) is predictive of adverse outcomes regardless of the absolute level. We aimed to examine the association between perioperative ΔHb and kidney transplantation (KT) outcomes.
METHODS METHODS
This was a retrospective cohort study of transplant recipients, where ΔHb = [Hb0- Hb1Hb0]x 100 (Hb
RESULTS RESULTS
Of the 899 eligible patients, 38% experienced IGF, and ΔHb was associated with 36% lower odds of IGF. Also, ΔHb was associated with higher all-cause graft failure and longer length of stay but not death-censored graft failure or mortality. ΔHb ≥30% was the threshold beyond which the odds of IGF were significantly lower even if Hb
CONCLUSION CONCLUSIONS
ΔHb is associated with inferior outcomes independent of Hb

Identifiants

pubmed: 33707078
pii: S0002-9610(21)00116-1
doi: 10.1016/j.amjsurg.2021.03.002
pii:
doi:

Substances chimiques

Hemoglobins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

825-831

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest Dr. Sandal has received an education grant from Amgen to increase living donor kidney transplantation. In the past five years, Dr Chaudhury discloses Ad board and honoraria from Ipsen and Novartis Oncology. Dr. Tchervenkov discloses that he has received a PI initiated Astellas/Canadian Society of Transplantation Research Support that ended in 2018. The other authors have no relevant disclosures.

Auteurs

Sarah MacIsaac (S)

Faculty of Medicine, McGill University, Montreal, Quebec, Canada. Electronic address: sarah.macisaac@mail.mcgill.ca.

Agnihotram V Ramanakumar (AV)

Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada. Electronic address: raman.agnihotram@muhc.mcgill.ca.

Chee Saw (C)

Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada; Division of Hematology, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada. Electronic address: chee.saw@mcgill.ca.

Veronique Naessens (V)

Division of Hematology, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada. Electronic address: veronique.naessens@mcgill.ca.

Nasim Saberi (N)

Department of Surgery, McGill University Health Centre, Montreal, Quebec, Canada. Electronic address: nasim.saberi@muhc.mcgill.ca.

Marcelo Cantarovich (M)

Division of Nephrology, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada. Electronic address: marcelo.cantarovich@mcgill.ca.

Dana Baran (D)

Division of Nephrology, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada. Electronic address: dana.baran@mcgill.ca.

Steven Paraskevas (S)

Department of Surgery, McGill University Health Centre, Montreal, Quebec, Canada. Electronic address: steven.paraskevas@mcgill.ca.

Jean Tchervenkov (J)

Department of Surgery, McGill University Health Centre, Montreal, Quebec, Canada. Electronic address: jean.tchervenkov@mcgill.ca.

Prosanto Chaudhury (P)

Department of Surgery, McGill University Health Centre, Montreal, Quebec, Canada. Electronic address: prosanto.chaudhury@mcgill.ca.

Shaifali Sandal (S)

Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada; Division of Nephrology, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada. Electronic address: shaifali.sandal@mcgill.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH